Trial intelligence / Profile preview

FAME2 fenofibrate trial in abdominal aortic aneurysm

ACTRN12613001039774Phase 4Completed

Sponsor
James Cook University
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in abdominal aortic aneurysm (AAA) comparing Fenofibrate with Placebo (2 arms). Primary endpoints: Serum osteopontin concentration and Serum kallistatin concentration. Started Nov 2013; status: completed.

02

Drugs

fenofibrate
03

Conditions

abdominal aortic aneurysm (AAA)

Beyond the preview

Go deeper on ACTRN12613001039774.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12613001039774.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call